J Pain Symptom Manage. 1995 Feb;10(2):167-70.

Methylphenidate for the management of somatization in terminal cancer patients.

Source

Palliative Care Program, Edmonton General Hospital, Alberta, Canada.

Abstract

We report a case that illustrates methylphenidate's (MP) usefulness in the management of psychological distress and associated somatization in the palliative-care setting. A 60-year-old man affected by terminal cancer of the prostate had been complaining of increasing physical pain, without any evidence of significant disease progression, opioid toxicity, or previous history of drug addiction. Because of patient's denial, the team had been unsuccessful in identifying any potential emotional factors affecting his physical suffering. MP could both counteract opioid-induced sedation and improve pain control through a positive action on patient's mood. In spite of a rapid development of tolerance, which required a subsequent escalation in MP daily doses, the drug was well tolerated and the patient could die in good physical comfort 2 weeks later.

PMID:: 7730689; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

Methylphenidate

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases

METHYLPHENIDATE - HSDB

Supplemental Content

Save items

Related citations in PubMed

The use of methylphenidate in patients with incident cancer pain receiving regular opiates. A preliminary report. [Pain. 1992]
The use of methylphenidate in patients with incident cancer pain receiving regular opiates. A preliminary report.
Bruera E, Fainsinger R, MacEachern T, Hanson J. Pain. 1992 Jul; 50(1):75-7.
Somatization disorder, a cause of difficult pain: a case report. [Am J Hosp Palliat Care. 2007]
Somatization disorder, a cause of difficult pain: a case report.
Gupta D, Mishra S, Bhatnagar S. Am J Hosp Palliat Care. 2007 Jun-Jul; 24(3):219-23.
Review Pain and symptom control in paediatric palliative care. [Cancer Surv. 1994]
Review Pain and symptom control in paediatric palliative care.
Stevens MM, Dalla Pozza L, Cavalletto B, Cooper MG, Kilham HA. Cancer Surv. 1994; 21:211-31.
Improved opioid analgesic effect following opioid dose reduction. [Pain Med. 2008]
Improved opioid analgesic effect following opioid dose reduction.
Vorobeychik Y, Chen L, Bush MC, Mao J. Pain Med. 2008 Sep; 9(6):724-7.
Review Somatization disorder and cancer: a case history and review. [Palliat Support Care. 2004]
Review Somatization disorder and cancer: a case history and review.
Thomas T, Booth S, Earl H, Lennox G. Palliat Support Care. 2004 Dec; 2(4):409-13.

See reviews... See all...

Cited by 1 PubMed Central article

Neuropharmacological mechanisms underlying the neuroprotective effects of methylphenidate. [Curr Neuropharmacol. 2008]
Neuropharmacological mechanisms underlying the neuroprotective effects of methylphenidate.
Volz TJ. Curr Neuropharmacol. 2008 Dec; 6(4):379-85.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Methylphenidate for the management of somatization in terminal cancer patients.
Methylphenidate for the management of somatization in terminal cancer patients.
J Pain Symptom Manage. 1995 Feb ;10(2):167-70.

PubMed
Effects of different patterns of stairclimbing on physiological cost and motor e...
Effects of different patterns of stairclimbing on physiological cost and motor efficiency.
J Hum Ergol (Tokyo). 1994 Dec ;23(2):111-20.

PubMed
Activating transcription factor 1 and cyclic AMP response element modulator can ...
Activating transcription factor 1 and cyclic AMP response element modulator can modulate the activity of the immunoglobulin kappa 3' enhancer.
J Biol Chem. 1995 Apr 28 ;270(17):10304-13.

PubMed
Organization and growth phase-dependent transcription of methane genes in two re...
Organization and growth phase-dependent transcription of methane genes in two regions of the Methanobacterium thermoautotrophicum genome.
J Bacteriol. 1995 May ;177(9):2460-8.

PubMed
Salt stress is an environmental signal affecting degradative enzyme synthesis in...
Salt stress is an environmental signal affecting degradative enzyme synthesis in Bacillus subtilis.
J Bacteriol. 1995 May ;177(9):2403-7.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: